GeneDx Holdings Corp. Fair Value Adjustment of Warrants
GeneDx Holdings Corp. (WGS) reported Fair Value Adjustment of Warrants of -$2.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-03
- GeneDx Holdings Corp. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$220.00K.
- GeneDx Holdings Corp. fair value adjustment of warrants for the quarter ending 2026-03-31 was -$2.54M, a 330.91% decline year-over-year.
- GeneDx Holdings Corp. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$1.12M, a 156.36% decline year-over-year.
- GeneDx Holdings Corp. fair value adjustment of warrants for the quarter ending 2025-09-30 was $3.40M, a 286.48% increase year-over-year.
- GeneDx Holdings Corp. fair value adjustment of warrants for fiscal 2025 was $1.20M, a 90.99% decline from fiscal 2024.
- GeneDx Holdings Corp. fair value adjustment of warrants for fiscal 2024 was $13.37M.
- GeneDx Holdings Corp. fair value adjustment of warrants for fiscal 2023 was -$1.17M.
- GeneDx Holdings Corp. fair value adjustment of warrants for fiscal 2022 was -$70.23M.
| Period end | Fair Value Adjustment of Warrants 2 month | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$220.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$2.76M 10-Q · filed 2026-08-03 | -$3.88M derived: sum of 3 quarters · filed 2026-08-03 | -$475.00K derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | -$2.54M 10-Q · filed 2026-05-04 | -$3.66M derived: sum of 2 quarters · filed 2026-05-04 | -$255.00K derived: sum of 3 quarters · filed 2026-05-04 | -$2.44M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.29M derived: sum of 2 quarters · filed 2026-02-23 | $104.00K derived: sum of 3 quarters · filed 2026-08-03 | $1.20M 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.22M derived: sum of 2 quarters · filed 2026-08-03 | $2.32M 10-Q · filed 2025-10-28 | $4.30M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | -$2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$1.08M 10-Q · filed 2026-08-03 | $899.00K derived: sum of 3 quarters · filed 2026-08-03 | $1.78M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-03-31 | $1.10M 10-Q · filed 2026-05-04 | $3.08M derived: sum of 2 quarters · filed 2026-05-04 | $3.96M derived: sum of 3 quarters · filed 2026-05-04 | $8.37M derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.86M derived: sum of 2 quarters · filed 2026-02-23 | $7.27M derived: sum of 3 quarters · filed 2026-02-23 | $13.37M 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $880.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $5.29M derived: sum of 2 quarters · filed 2025-10-28 | $11.39M 10-Q · filed 2025-10-28 | $10.90M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | $4.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $10.51M 10-Q · filed 2025-07-29 | $10.02M derived: sum of 3 quarters · filed 2026-02-23 | $9.43M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | $6.10M 10-Q · filed 2025-04-30 | $5.62M derived: sum of 2 quarters · filed 2026-02-23 | $5.03M derived: sum of 3 quarters · filed 2026-02-23 | $1.48M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | -$486.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$1.08M derived: sum of 2 quarters · filed 2026-02-23 | -$4.62M derived: sum of 3 quarters · filed 2026-02-23 | -$1.17M 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | -$590.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$4.14M derived: sum of 2 quarters · filed 2024-10-29 | -$684.00K 10-Q · filed 2024-10-29 | -$685.00K 10-Q · filed 2023-11-03 | -$16.56M derived: sum of 4 quarters · filed 2024-10-29 | |||
| 2023-06-30 | -$3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$94.00K 10-Q · filed 2024-07-30 | -$15.97M derived: sum of 3 quarters · filed 2024-07-30 | -$28.95M derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2023-03-31 | $3.45M 10-Q · filed 2024-04-29 | -$12.43M derived: sum of 2 quarters · filed 2024-04-29 | -$25.40M derived: sum of 3 quarters · filed 2024-04-29 | -$53.59M derived: sum of 4 quarters · filed 2024-04-29 | ||||
| 2022-12-31 | -$15.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$28.86M derived: sum of 2 quarters · filed 2024-02-23 | -$57.04M derived: sum of 3 quarters · filed 2024-02-23 | -$70.23M 10-K · filed 2024-02-23 | ||||
| 2022-09-30 | -$12.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$41.16M derived: sum of 2 quarters · filed 2023-11-03 | -$54.35M 10-Q · filed 2023-11-03 | -$130.58M derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | -$28.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$41.37M 10-Q · filed 2023-08-08 | -$117.60M derived: sum of 3 quarters · filed 2023-08-08 | -$239.77M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | -$13.19M 10-Q · filed 2023-05-09 | -$89.42M derived: sum of 2 quarters · filed 2023-05-09 | -$211.59M derived: sum of 3 quarters · filed 2023-05-09 | -$225.87M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$76.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$198.40M derived: sum of 2 quarters · filed 2023-03-16 | -$212.68M derived: sum of 3 quarters · filed 2023-03-16 | -$198.40M 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | $81.70M 10-Q · filed 2021-11-15 | -$122.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$136.45M derived: sum of 2 quarters · filed 2022-11-14 | -$122.17M 10-Q · filed 2022-11-14 | -$136.45M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-06-30 | -$14.28M 10-Q · filed 2021-07-21 | $0.00 10-Q · filed 2022-08-15 | $42.36M 10-Q · filed 2021-07-21 | -$14.28M derived: sum of 3 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | $56.64M 10-Q · filed 2021-05-24 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $38.51M 10-K/A · filed 2021-05-05 | $0.00 10-K · filed 2023-03-16 | |||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | |||||||
| 2019-12-31 | $0.00 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |